Frontiers in Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: June 10, 2022
Cerebral
ischemia
reperfusion
injury
is
a
debilitating
medical
condition,
currently
with
only
limited
amount
of
therapies
aimed
at
protecting
the
cerebral
parenchyma.
Micro
RNAs
(miRNAs)
are
small,
non-coding
RNA
molecules
that
via
RNA-induced
silencing
complex
either
degrade
or
prevent
target
messenger
from
being
translated
and
thus,
can
modulate
synthesis
proteins.
In
neurological
field,
miRNAs
have
been
evaluated
as
potential
regulators
in
brain
development
processes
pathological
events.
Following
ischemic
hypoxic
stress,
cellular
molecular
events
initiated
dysregulate
different
miRNAs,
responsible
for
long-terming
progression
extension
neuronal
damage.
Because
their
ability
to
regulate
proteins,
emerge
possible
therapeutic
strategy
limiting
damage
following
event.
This
review
aims
summarize
recent
literature
evidence
involved
signaling
modulating
ischemia-reperfusion
injuries,
thus
pointing
repair
mechanisms.
An
in-depth
overview
pathways
involvement
specific
could
provide
future
perspectives
neuroprotective
agents
targeting
these
miRNAs.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(11), P. 6224 - 6224
Published: June 2, 2022
Vascular
cognitive
impairment
and
dementia
(VCID)
is
a
major
heterogeneous
brain
disease
caused
by
multiple
factors,
it
the
second
most
common
type
of
in
world.
It
long-term
chronic
low
perfusion
whole
or
local
area,
eventually
develops
into
severe
dysfunction
syndrome.
Because
disease's
ambiguous
classification
diagnostic
criteria,
there
no
clear
treatment
strategy
for
VCID,
association
between
cerebrovascular
pathology
controversial.
Neuroinflammation
an
immunological
cascade
reaction
mediated
glial
cells
central
nervous
system
where
innate
immunity
resides.
Inflammatory
reactions
could
be
triggered
various
damaging
events,
including
hypoxia,
ischemia,
infection.
Long-term
hypoperfusion-induced
ischemia
hypoxia
can
overactivate
neuroinflammation,
causing
apoptosis,
blood-brain
barrier
damage
other
pathological
changes,
triggering
aggravating
occurrence
development
VCID.
In
this
review,
we
will
explore
mechanisms
neuroinflammation
induced
hypoperfusion
emphasize
important
role
VCID
from
perspective
immune
cells,
mediators
signaling
pathways,
so
as
to
provide
valuable
ideas
prevention
disease.
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(3), P. 574 - 574
Published: March 1, 2022
Recanalization
therapy
is
increasingly
used
in
the
treatment
of
acute
ischemic
stroke.
However,
about
one
third
these
patients,
recanalization
followed
by
ischemia/reperfusion
injuries,
and
clinically
to
worsening
neurological
status.
Much
research
has
focused
on
unraveling
involved
mechanisms
order
prevent
or
efficiently
treat
injuries.
What
we
know
so
far
that
oxidative
stress
mitochondrial
dysfunction
are
significantly
pathogenesis
injury.
despite
promising
results
obtained
experimental
research,
clinical
studies
trying
interfere
with
pathways
have
mostly
failed.
The
current
article
discusses
main
leading
such
as
dysfunction,
excitotoxicity,
stress,
reviews
trials
antioxidant
molecules
highlighting
recent
developments
future
strategies.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(3), P. 1869 - 1869
Published: Jan. 18, 2023
Aging
is
the
most
prominent
risk
factor
for
late-onset
Alzheimer’s
disease.
associates
with
a
chronic
inflammatory
state
both
in
periphery
and
central
nervous
system,
evidence
thereof
mechanisms
leading
to
neuroinflammation
being
discussed.
Nonetheless,
significantly
enhanced
by
accumulation
of
amyloid
beta
accelerates
progression
disease
through
various
pathways
discussed
present
review.
Decades
clinical
trials
targeting
2
abnormal
proteins
disease,
tau,
led
many
failures.
As
such,
via
different
strategies
could
prove
valuable
therapeutic
strategy,
although
much
research
still
needed
identify
appropriate
time
window.
Active
focusing
on
identifying
early
biomarkers
help
translating
these
novel
from
bench
bedside.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(7), P. 6328 - 6328
Published: March 28, 2023
Neuroinflammation
is
a
critical
factor
in
developing
and
progressing
numerous
brain
diseases,
including
neurodegenerative
diseases.
Chronic
or
excessive
neuroinflammation
can
lead
to
neurotoxicity,
causing
damage
contributing
the
onset
progression
of
various
Therefore,
understanding
mechanisms
strategies
control
them
crucial
for
treating
Studies
have
shown
that
plays
vital
role
such
as
Alzheimer's
(AD)
Parkinson's
(PD),
stroke.
Additionally,
effects
PM
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
168, P. 115653 - 115653
Published: Oct. 7, 2023
The
modulation
of
microglial
polarization
from
the
pro-inflammatory
M1
to
anti-inflammatory
M2
phenotype
shows
promise
as
a
therapeutic
strategy
for
ischemic
stroke.
Quercetin,
natural
flavonoid
abundant
in
various
plants,
possesses
anti-inflammatory,
anti-apoptotic,
and
antioxidant
properties.
Nevertheless,
its
effect
underlying
mechanism
on
microglia/macrophages
M1/M2
treatment
cerebral
ischemia/reperfusion
injury
(CI/RI)
remain
poorly
explored.
In
current
study,
we
observed
that
quercetin
ameliorated
neurological
deficits,
reduced
infarct
volume,
decreased
number
(CD16/32+/Iba1+),
enhanced
(CD206+/Iba1+)
after
establishing
CI/RI
model
rats.
Subsequent
vivo
vitro
experiments
indicated
downregulated
markers
(CD86,
iNOS,
TNF-α,
IL-1β,
IL-6)
upregulated
(CD206,
Arg-1,
IL-10,
TGF-β).
Network
pharmacology
analysis
molecular
docking
revealed
PI3K/Akt/NF-κB
signaling
pathway
emerged
core
pathway.
Western
blot
confirmed
phosphorylation
PI3K
Akt,
while
alleviating
IκBα
NF-κB
both
vitro.
However,
inhibitor
LY294002
reversed
effects
expression
key
proteins
primary
microglia
oxygen-glucose
deprivation/reoxygenation
(OGD/R)
Collectively,
our
findings
demonstrate
facilitates
by
modulating
CI/RI.
These
provide
novel
insights
into
mechanisms
Neurochemical Research,
Journal Year:
2022,
Volume and Issue:
47(10), P. 2992 - 3002
Published: June 20, 2022
To
clarify
the
potential
role
of
selenium
(Se)
on
cerebral
ischemia/reperfusion
(I/R)
injury,
we
utilized
mouse
middle
artery
occlusion
(MCAO)
followed
by
reperfusion
as
an
animal
model
and
oxygen-glucose
deprivation
reoxygenation
(OGD/R)
to
treat
N2a
cells
a
cell
model,
respectively.
MCAO
was
established
in
mice
then
divided
into
different
groups
with
or
without
Se
treatment.
TTC
staining
used
observe
whether
I/R
modeling
successful,
apoptosis
level
determined
TUNEL
staining.
The
expression
GPx-4
p22phox
assessed
western
blot.
In
vitro
experiments,
OGD/R
induced
oxidative
stress
levels
GSH/GSSG,
malondialdehyde,
superoxide
dismutase
iron
content,
QRT-PCR
detect
mRNA
Cox-2,
Fth1,
Mfn1
mtDNA
cells.
JC-1
flow
cytometry
performed
mitochondrial
membrane
potential.
treatment
alleviated
injury
improved
survival
rate
mice.
Additionally,
apparently
attenuated
inhibited
accumulation
terms
its
mechanism,
could
up-regulate
alleviate
ferroptosis
promoting
fusion
vivo
vitro.
These
findings
suggest
that
may
have
great
alleviating
injury.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(21)
Published: March 23, 2024
Abstract
Traumatic
brain
injuries
(TBI)
and
stroke
are
major
causes
of
morbidity
mortality
in
both
developing
developed
countries.
The
complex
heterogeneous
pathophysiology
TBI
cerebral
ischemia‐reperfusion
injury
(CIRI),
addition
to
the
blood‐brain
barrier
(BBB)
resistance,
is
a
advancement
diagnostics
therapeutics.
Clinical
data
showed
that
severity
positively
correlated
with
number
neutrophils
peripheral
blood
sites.
Furthermore,
neutrophil
extracellular
traps
(NETs)
released
by
correlate
worse
outcomes
impairing
revascularization
vascular
remodeling.
Therefore,
targeting
deliver
NETs
inhibitors
sites
reduce
formation
can
be
an
optimal
strategy
for
therapy.
Herein,
study
designs
synthesizes
reactive
oxygen
species
(ROS)‐responsive
neutrophil‐targeting
delivery
system
loaded
peptidyl
arginine
deiminase
4
(PAD4)
inhibitor,
GSK484,
prevent
sites,
which
significantly
inhibited
neuroinflammation
improved
neurological
deficits,
survival
rate
CIRI.
This
may
provide
groundwork
development
targeted
theranostics
stroke.
Translational Stroke Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 14, 2024
Abstract
Stroke
in
China
is
distinguished
by
its
high
rates
of
morbidity,
recurrence,
disability,
and
mortality.
The
ultra-early
administration
rtPA
essential
for
restoring
perfusion
acute
ischemic
stroke,
though
it
concurrently
elevates
the
risk
hemorrhagic
transformation.
High-mobility
group
box
1
(HMGB1)
emerges
as
a
pivotal
player
neuroinflammation
after
brain
ischemia
ischemia–reperfusion.
Released
passively
necrotic
cells
actively
secreted,
including
direct
secretion
HMGB1
into
extracellular
space
packaging
intracellular
vesicles
immune
cells,
glial
platelets,
endothelial
represents
prototypical
damage-associated
molecular
pattern
(DAMP).
It
intricately
involved
pathogenesis
atherosclerosis,
thromboembolism,
detrimental
inflammation
during
early
phases
stroke.
Moreover,
significantly
contributes
to
neurovascular
remodeling
functional
recovery
later
stages.
Significantly,
mediates
transformation
facilitating
neuroinflammation,
directly
compromising
integrity
blood–brain
barrier,
enhancing
MMP9
through
interaction
with
rtPA.
As
systemic
inflammatory
factor,
also
implicated
post-stroke
depression
an
elevated
stroke-associated
pneumonia.
role
extends
influencing
polarizing
various
subtypes
cells.
This
includes
mediating
excitotoxicity
due
excitatory
amino
acids,
autophagy,
release,
NET
formation,
autocrine
trophic
pathways.
Given
multifaceted
role,
recognized
crucial
therapeutic
target
prognostic
marker
stroke
In
this
review,
we
summarize
structure
redox
properties,
pathways,
regulation
cell
activity,
pathophysiological
mechanisms
hemorrhage
HMGB1,
which
will
pave
way
developing
new
neuroprotective
drugs,
reduction
expansion
thrombolysis
time
window.